Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Eddie Lampert, Citadel Investment Group, Point72, Axon Enterprise Inc (AAXN), Strongbridge Biopharma PLC (SBBP), and More

Insider Selling: Axon Enterprise Inc (NASDAQ:AAXN) CEO Sells 107,000 Shares of Stock (FairFieldCurrent.com)
Axon Enterprise Inc (NASDAQ:AAXN) CEO Patrick W. Smith sold 107,000 shares of the stock in a transaction that occurred on Thursday, December 20th. The stock was sold at an average price of $42.27, for a total value of $4,522,890.00. Following the sale, the chief executive officer now directly owns 632,520 shares in the company, valued at approximately $26,736,620.40. The sale was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Strongbridge Biopharma plc (SBBP) Major Shareholder Buys 146,467 Shares of Stock (PressOracle.com)
Strongbridge Biopharma plc (NASDAQ:SBBP) major shareholder Associates L.L.C. Cdk purchased 146,467 shares of Strongbridge Biopharma stock in a transaction on Thursday, December 20th. The stock was bought at an average cost of $4.00 per share, with a total value of $585,868.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission.

Insider Selling: Virtusa Co. (VRTU) CEO Sells 12,000 Shares of Stock (WeekHerald.com)
Virtusa Co. (NASDAQ:VRTU) CEO Kris A. Canekeratne sold 12,000 shares of the business’s stock in a transaction dated Friday, January 4th. The shares were sold at an average price of $42.06, for a total transaction of $504,720.00. Following the completion of the sale, the chief executive officer now directly owns 661,387 shares of the company’s stock, valued at approximately $27,817,937.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Insider Selling: Teladoc Health Inc (NYSE:TDOC) CEO Sells 30,000 Shares of Stock (PressOracle.com)
Teladoc Health Inc (NYSE:TDOC) CEO Jason N. Gorevic sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, December 19th. The stock was sold at an average price of $49.55, for a total value of $1,486,500.00. Following the transaction, the chief executive officer now directly owns 536,184 shares in the company, valued at approximately $26,567,917.20. The sale was disclosed in a document filed with the Securities & Exchange Commission.

Insider Selling: Docusign Inc (DOCU) Director Sells 51,982 Shares of Stock (FairFieldCurrent.com)
Docusign Inc (NASDAQ:DOCU) Director Keith J. Krach sold 51,982 shares of the business’s stock in a transaction on Friday, December 21st. The shares were sold at an average price of $40.34, for a total transaction of $2,096,953.88. The sale was disclosed in a legal filing with the SEC.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...